Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03860311 · ClinicalTrials.gov registry record · NA
BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment
A NA study of Point-of-Care Bladder Ultrasound and Urethral Catheter, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT03860311: Completed NA study of Point-of-Care Bladder Ultrasound and Urethral Catheter, sponsored by University of Alabama at Birmingham.
NCT03860311 is a NA study of Point-of-Care Bladder Ultrasound and Urethral Catheter that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03860311, a NA study of Point-of-Care Bladder Ultrasound and Urethral Catheter, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study patients presenting to the pediatric ER with abdominal or pelvic complaints will be randomized to urethral bladder catheter or bladder ultrasound to compare time to completion of successful pelvic ultrasound, as determined by full visualization of uterus and ovaries.
Primary Outcome
Time zero (order placed) to time completed (time pelvic ultrasound images are completed)
Conditions Studied
Interventions
- OTHER Standard of Care
- DEVICE Bladder Ultrasound
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-07-20 |
| Est. Completion | 2021-05-01 |
| Phase | NA |
What the finished NCT03860311 record still lists
NCT03860311 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Point-of-Care Bladder Ultrasound appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT03860311 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03860311 about?
NCT03860311 is a clinical study titled "BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment". In this study patients presenting to the pediatric ER with abdominal or pelvic complaints will be randomized to urethral bladder catheter or bladder ultrasound to compare time to completion of successful pelvic ultrasound, as determined by full visualization of uterus and ovaries.
What is the current status of trial NCT03860311?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-07-20. Estimated completion is 2021-05-01.
What conditions does trial NCT03860311 study?
This clinical trial studies the following conditions: Point-of-Care Bladder Ultrasound, Urethral Catheter.
What interventions are being tested in trial NCT03860311?
The interventions under investigation include: Standard of Care (OTHER), Bladder Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03860311?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03860311 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03860311's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI